Publications in collaboration with researchers from Hospital Universitario Central de Asturias (23)

2024

  1. Patología neurovascular en el paciente con neurofibromatosis de tipo 1. A propósito de un caso

    Revista de neurologia, Vol. 79, Núm. 4, pp. 115-118

2022

  1. Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy

    Cerebrovascular Diseases Extra, Vol. 12, Núm. 3, pp. 103-108

2020

  1. Dual energy CT in the management of antiplatelet therapy in patients with acute ischemic stroke for carotid obstruction

    Interventional Neuroradiology, Vol. 26, Núm. 2, pp. 222-230

  2. No association between migraine frequency, white matter lesions and silent brain infarctions: a study in a series of women with chronic migraine

    European Journal of Neurology, Vol. 27, Núm. 8, pp. 1689-1696

2019

  1. Global Orbital Infarction Syndrome after a Carotid Artery Dissection

    JAMA Neurology

  2. Orthostatic tremor as the only manifestation of thyrotoxicosis following cerebral angiography

    Neurologia

2016

  1. Analysis of endovascular treatment of ruptured microaneurysms compared with ruptured larger aneurysms

    Journal of NeuroInterventional Surgery, Vol. 8, Núm. 6, pp. 586-590

  2. Convexity subarachnoid haemorrhage secondary to internal carotid stenosis: An indication for revascularisation

    BMJ Case Reports, Vol. 2016

  3. El código ictus de Asturias

    Neurologia, Vol. 31, Núm. 3, pp. 143-148

  4. No Relationship Between Patent Foramen Ovale and Migraine Frequency

    Headache, Vol. 56, Núm. 9, pp. 1466-1473

  5. Safety and Efficacy of Mechanical Thrombectomy in Acute Ischemic Stroke of Anticoagulated Patients—A Prospective Observational Study

    Journal of Stroke and Cerebrovascular Diseases, Vol. 25, Núm. 9, pp. 2093-2098

2015

  1. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine

    Cephalalgia, Vol. 35, Núm. 4, pp. 310-316

  2. Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?

    Cephalalgia, Vol. 35, Núm. 10, pp. 864-868

  3. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine

    Pain, Vol. 156, Núm. 5, pp. 820-824

2014

  1. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine

    Headache, Vol. 54, Núm. 6, pp. 987-995

  2. Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions

    Journal of the Neurological Sciences, Vol. 336, Núm. 1-2, pp. 180-183

  3. Yield of Holter and echocardiography in the screening of TIA

    International Journal of Cardiology, Vol. 172, Núm. 2, pp. 483-485

2013

  1. Hemichorea secondary to contralateral pontine haemorrhage

    Parkinsonism and Related Disorders

  2. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

    Neurology, Vol. 81, Núm. 14, pp. 1191-1196

  3. Long term evolution of patients treated in a TIA unit

    International Archives of Medicine, Vol. 6, Núm. 1